Experiment 310125

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

LANOST-8-EN-23-ONE,27-NOR: 3-BETA-[(O-BETA-D-APIONFURANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-24-EPOXY-28-29-DIHYDROXY: 23(S):

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismChionodoxa luciliae (LILIACEAE)
CitationORI,K: KURODA,M: MIMAKI,Y: SAKAGAMI,H: SASHIDA,Y:. (2003). NORLANOSTANE AND LANOSTANE GLYCOSIDES FROM THE BULBS OF CHIONODOXA LUCILIAE AND THEIR CYTOTOXIC ACTIVITY.. 51(1)
Amount utilized
Compound isolated
DiseaseVS.HSC-2 CELLS.
Dose amount>50.0 MCG
Number4
Qualitative resultINACTIVE
AnimalCELL CULTURE
Per unitML
Dose expressionIC50